BioNTech says it will know in 2 weeks whether the COVID-19 vaccine it developed with Pfizer works against the new variant rapidly spreading in southern Africa
- BioNTech is testing its
COVID vaccineagainst a rapidly spreading variant, the Financial Times said.
B.1.1.529variant has been detected in South Africa, Botswana, Hong Kong, and Israel.
View all Offers
Wipro Alivio Mid Back Mesh Ergonomic Home-Office Chair with Synchro tilt Mechanism,Adjustable armrest,Cushion Lumbar,Durable Nylon Frame,5yr wrnty,BIFMA & Green Certified,Premium Fabric (Black)₹ 10589₹ 17800Buy On
- 22% OFF
Sleepwell Starlite Discover 5-inch Firm Double Size Foam Mattress (72*48*4 Inches)₹ 4399₹ 4879Buy On
- 42% OFF
Ebee 8 Pair Metal Shoe Stand (Blue, 4 Shelves)₹ 519₹ 899Buy On
Savya Home® APEX Chairs™ Apollo Chrome Base HIGH Back Office CHAIR2₹ 5089₹ 18000Buy On
AmazonBasics Mid Back Office Chair (Black, Leather)₹ 5999₹ 11000Buy On
BioNTech said it's testing the
The variant has 32 mutations in the part of the virus that attaches to human cells, called the spike protein — the target for existing vaccines and antibody treatments. This means there is a greater risk that those vaccines and treatments won't be as effective against it, Insider previously reported.
"We understand the concern of experts and have immediately initiated investigations on variant B.1.1.529," BioNTech told Insider. "We expect more data from the laboratory tests in two weeks at the latest."
The company said the variant "differs significantly from previously observed variants."
"Pfizer and BioNTech have taken actions months ago to be able to adapt the mRNA vaccine within six weeks and ship initial batches within 100 days in the event of an escape variant," the company said.
"To that end, the companies have begun clinical trials with variant-specific vaccines (alpha and delta) to collect safety and tolerability data that can be provided to regulators," the company continued.
It's unknown whether the mutations make the B.1.1.529 variant more infectious or deadly.
The variant is rapidly spreading. Israel reported its first case of B.1.1.529 on Friday — someone who returned to Israel from Malawi.
Data shared by South Africa's Department of Health on Thursday showed that B.1.1.529 made up about 75% of cases detected in Gauteng province on November 22, just two weeks after the variant first emerged. Its ascent was much faster than that of the Beta and Delta variants, which each took months to become dominant, Insider reported.
- pi Ventures plans to invest in 25 young startups with its latest $75 million fund
- Best deals on hair straighteners, trimmers and other grooming products on Amazon
- Amazon Republic Day Sale 2022 — Best deals and offers on Echo smart speakers, Fire TV Sticks and more
- Two IndiGo planes avert mid-air collision over Bengaluru airport, DGCA to take strict action
- India's tennis star Sania Mirza announces retirement from the sport by the end of 2022 season